Introduction to the session
The aim of the article is to capture the session at EuroPCR 2016, communicate the analysis of the trialist, and report the views expressed in the interactive discussion. The article does not constitute an independent review of the topic by the authors. The session focused on whether the PARTNER 2 Cohort A trial will change clinical practice1.
The introductory comments highlighted that the indications for TAVI in 2016 are “frozen in time”, being based upon ESC and ACC/AHA guidelines published in 2012 and 2014, respectively. The pivotal PARTNER 1 trial demonstrated the utility of TAVI in ...
Sign in to read and download the full articleForgot your password?
Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com